Alamar Biosciences, Inc. · NASDAQ:ALMR
Qiming Corporate GP VI, Ltd. sold 217,512 Alamar Biosciences, Inc. shares (Form 4)
Traded Oct 19 to Oct 20, 2026 · Filed Oct 21, 2026
From Oct 19 to Oct 20, 2026, Qiming Corporate GP VI, Ltd. (10% owner) sold 217,512 Alamar Biosciences, Inc. shares at an average US$27.35 for US$5.95M, leaving 1,851,350 shares. Filed Oct 21, 2026 (Form 4).
- Sold
- 217,512 shares
- Price
- US$27.35 average (US$26.34 to US$28.44)
- Value
- US$5.95M
- Holding after
- 1,851,350 shares (held indirectly)
- Trading plan
- No
- Role
- 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 19, 2026 | Common Stock | Sale | 1,320 | US$26.34 | 180,808 | Indirect |
| Oct 19, 2026 | Common Stock | Sale | 49,044 | US$26.34 | 6,719,561 | Indirect |
| Oct 19, 2026 | Common Stock | Sale | 11,443 | US$26.34 | 1,567,881 | Indirect |
| Oct 19, 2026 | Common Stock | Sale | 13,701 | US$26.34 | 1,877,116 | Indirect |
| Oct 20, 2026 | Common Stock | Sale | 200 | US$26.63 | 180,608 | Indirect |
| Oct 20, 2026 | Common Stock | Sale | 1,947 | US$27.93 | 178,661 | Indirect |
| Oct 20, 2026 | Common Stock | Sale | 335 | US$28.44 | 178,326 | Indirect |
| Oct 20, 2026 | Common Stock | Sale | 7,415 | US$26.63 | 6,712,146 | Indirect |
| Oct 20, 2026 | Common Stock | Sale | 72,373 | US$27.93 | 6,639,773 | Indirect |
| Oct 20, 2026 | Common Stock | Sale | 12,447 | US$28.44 | 6,627,326 | Indirect |
| Oct 20, 2026 | Common Stock | Sale | 1,730 | US$26.63 | 1,566,151 | Indirect |
| Oct 20, 2026 | Common Stock | Sale | 16,887 | US$27.93 | 1,549,264 | Indirect |
| Oct 20, 2026 | Common Stock | Sale | 2,904 | US$28.44 | 1,546,360 | Indirect |
| Oct 20, 2026 | Common Stock | Sale | 2,072 | US$26.63 | 1,875,044 | Indirect |
| Oct 20, 2026 | Common Stock | Sale | 20,217 | US$27.93 | 1,854,827 | Indirect |
| Oct 20, 2026 | Common Stock | Sale | 3,477 | US$28.44 | 1,851,350 | Indirect |
Source
Download original · View original at SEC
Related
- Alamar Biosciences, Inc.
- Qiming Corporate GP VI, Ltd.
- Alamar Biosciences, Inc. shareholders
- Form 4 · Qiming Corporate GP VI, Ltd. · Oct 19, 2026
- Form 4 · Brottem John L. · Sep 16, 2026
- Form 4 · Ragusa Robert P · Sep 3, 2026
- Schedule 13G · Yuling Luo · Aug 13, 2026
- Schedule 13G · Qiming Corporate GP VI, Ltd. · Aug 11, 2026
- Schedule 13D/A · Sands Capital Life Sciences Pulse Fund II, L.P. · Jul 7, 2026